C-D SHARK CARTILAGE 500mg :: CD 8501

CD Shark Cartilage, a trademarked name, is the result of over 20 years research in shark cartilage. It is 100% pure, using the most advanced, chemical-free processing techniques to ensure maximum strength and efficacy. May be effective in helping arthritis and cancer. Also helps maintain proper bone and joint function. Chondroitin and glucosamine sulphate occur naturally in our shark cartilage and CD Shark Cartilage has a fresh, clean taste and smell.

Shark Cartilage, in the true sense of the term, is just that - cartilage tissue from a shark.

Packaging specifications:
Shark Cartilage 500mg: Packed 96 per carton.
Carton size: 278 x 209 x 253 (0.015m³)
Carton Weight: 9.6 kg.


Assured Quality

CD Shark Cartilage is produced with processes for cleaning, drying, pulverizing and sterilising shark cartilage that ensure the highest quality and reliability without rendering the active protein fibers ineffective. Much research, testing, and management is necessarily involved in the development and production of high-quality, "clinical-grade," shark cartilage products suitable for human consumption. Processing shark cartilage without rendering the active protein fibers ineffective presents major problems, many of which are not addressed by other manufacturers of inferior shark cartilage products. Conventional cleaning, drying, pulverization, and sterilization processes with their excessive heat and/or use of harsh solvents or chemicals often denature the active protein and render the cartilage therapeutically valueless. Proteins are easily denatured by heat and other manufacturing processes and by various chemicals like solvents and acids that are designed to remove fats and other unneeded components.

INFORMATION - Shark Cartilage and Joint Health: The Clinical Research

There are many components of shark cartilage that are known to exert beneficial effects on bone and joint health. Shark cartilage is a rich source of chondroitin and glycosaminoglycans (glucosamine-like compounds), both of which have been described as natural anti-inflammatory agents. In the case of glucosamine-like compounds, prospective clinical trials in humans have shown evidence of cartilage renewal in joints with advanced changes of osteoarthritis. The role of type II collagen of foreign origin (shark, chicken or bovine) in the induction of oral tolerisation in immune types of arthritis (e.g. rheumatoid disease) has been well documented. Excellent clinical results in the improvement of inflammatory arthritis with type II collagen have been reported. Various types of arthritis may be amenable to therapy with antiangiogenic compounds such as shark cartilage. Animal studies show it has major potential application in the treatment of pain and inflammation associated with arthritis. Several researchers have reported a clear association between neovascularization and osteoarthritis, adding weight to the rationale of using cartilage to treat arthritis. Shark cartilage is also a rich source of bioavailable calcium, which is beneficial for patients with osteoporosis who require calcium supplementation.

Shark Cartilage Research

The following clinical trial abstracts are valuable in understanding the role of orally administered shark cartilage therapy in angiogenesis inhibition:

  1. Vargas, Dr. Pedro Elias, Shark Cartilage Treatment in Venezuela, Nutritional Oncology Adjuvant Therapy 4th Annual Congress, October 1998
  2. Davis PF, He Y, Furneaux PH, Johnston PS, Ruger BM, Slim GC Inhibition of angiogenesis of powdered shark cartilage in a rat model, Wellin_qtol7 Scl7ool of Medicine Bulletin 1997 Aug: 545-7
  3. Oikawa T. Ashino-Fuse H, Shimamura M, Koide U, and lwaguchi T, A novel angiogenic inhibitor derived from Japanese shark cartilage, Cancer Letters 51, 1990 181-186 Lane, IW, Institute 3ules Bordet, Brussels, Belgium Effect of cartilage administration against a human melanoma xenograft (MEXF 514) in nude mice, COMPREHENSIVE RESEARCH Papers on the THERAPEUTIC Use of Shark CARTILAGE, 1989
  4. Lopez Jose, Rodriguez Jose, Lane IW, Previous Human Experience - Cuban Clinical Trial, American Academy of Anti-Aging Medicine, Educational Conference, August, 1998
  5. Lane, IW, In vivo Evaluation of Whole Shark Cartilage and its Analogs in PC-3 Human Prostate Cancer Xenograft Models, Nutritional Oncology Adjuvant Therapy 4TH Annual Congress, October 1998
  6. In addition, two studies will be presented at the American Society of Clinical Oncologists' annual meeting in May. The first shows significant tumor growth retardation in animals fed BeneFin shark cartilage orally versus the control, and the second shows stabilization of fast-growing glioblastoma in human patients.

For additional evidence of the efficacy of shark cartilage as an angiogenesis inhibitor:

  1. Brem H, Folkman J, Inhibition of tumor angiogenesis mediated by cartilage Journal of Experimental Medicine 1975, 141: 427-439
  2. D'Amore PA, Anti-angiogenesis a strategy for antimetastasis. Seminars In Thrombosis and Homeostasis 1988, 14: 73-78
  3. Moses MA, Sudhalter J, Langer R Identification of an inhibitor of Neovascularization from cartilage Science 1990 248: 1406-1410
  4. Lane IW, Contreras E , High rate of bioactivity (reduction in gross tumor size) observed in advanced cancer patients treated with shark cartilage material -Journal of Naturopathic Medicine 1992 31: 86-88
  5. Lane IW, Shark cartilage: its potential medicine applications -Journal of Advancement In Medicine 1991 4(4): 263-271
  6. Lee A. Langer R, Shark cartilage contains inhibitors of tumor angiogenesis. Science 1983 221: 1185-87

Warning:

Keep out of reach from children. Consult a health care professional first if you are pregnant or nursing, recovering from surgery or have a heart/circulatory condition or suffered a heart attack.

Copyright © 2004 Chalmers Dale & Co. Pty. Ltd. All rights reserved
www.chalmersdale.com.au - Terms and Conditions & Privacy Policy
[ back to home ]